Royal Bank of Canada’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.39M | Buy |
206,124
+23,288
| +13% | +$270K | ﹤0.01% | 2879 |
|
2025
Q1 | $1.6M | Buy |
182,836
+162,665
| +806% | +$1.42M | ﹤0.01% | 2819 |
|
2024
Q4 | $288K | Buy |
20,171
+2,189
| +12% | +$31.3K | ﹤0.01% | 4071 |
|
2024
Q3 | $406K | Buy |
17,982
+3,399
| +23% | +$76.7K | ﹤0.01% | 3848 |
|
2024
Q2 | $284K | Sell |
14,583
-11,519
| -44% | -$224K | ﹤0.01% | 4099 |
|
2024
Q1 | $979K | Buy |
26,102
+2,325
| +10% | +$87.2K | ﹤0.01% | 3099 |
|
2023
Q4 | $1.33M | Buy |
23,777
+11,135
| +88% | +$623K | ﹤0.01% | 2971 |
|
2023
Q3 | $522K | Buy |
12,642
+1,594
| +14% | +$65.8K | ﹤0.01% | 3540 |
|
2023
Q2 | $616K | Sell |
11,048
-1,680
| -13% | -$93.7K | ﹤0.01% | 3394 |
|
2023
Q1 | $709K | Sell |
12,728
-13,142
| -51% | -$732K | ﹤0.01% | 3268 |
|
2022
Q4 | $943K | Sell |
25,870
-7,737
| -23% | -$282K | ﹤0.01% | 3139 |
|
2022
Q3 | $956K | Sell |
33,607
-18,050
| -35% | -$513K | ﹤0.01% | 3069 |
|
2022
Q2 | $2.34M | Buy |
51,657
+4,708
| +10% | +$213K | ﹤0.01% | 2410 |
|
2022
Q1 | $3.57M | Sell |
46,949
-2,346
| -5% | -$178K | ﹤0.01% | 2209 |
|
2021
Q4 | $7.34M | Buy |
49,295
+17,341
| +54% | +$2.58M | ﹤0.01% | 1806 |
|
2021
Q3 | $4.65M | Buy |
31,954
+1,019
| +3% | +$148K | ﹤0.01% | 2037 |
|
2021
Q2 | $6.06M | Buy |
30,935
+795
| +3% | +$156K | ﹤0.01% | 1941 |
|
2021
Q1 | $5.46M | Buy |
30,140
+11,850
| +65% | +$2.15M | ﹤0.01% | 1913 |
|
2020
Q4 | $2.59M | Buy |
18,290
+10,384
| +131% | +$1.47M | ﹤0.01% | 2312 |
|
2020
Q3 | $986K | Buy |
7,906
+5,954
| +305% | +$743K | ﹤0.01% | 2865 |
|
2020
Q2 | $175K | Buy |
1,952
+702
| +56% | +$62.9K | ﹤0.01% | 4085 |
|
2020
Q1 | $78K | Sell |
1,250
-2,459
| -66% | -$153K | ﹤0.01% | 4432 |
|
2019
Q4 | $283K | Buy |
3,709
+3,626
| +4,369% | +$277K | ﹤0.01% | 3819 |
|
2019
Q3 | $4K | Buy |
+83
| New | +$4K | ﹤0.01% | 5469 |
|